Marlot van der Wal

698 total citations
15 papers, 384 citations indexed

About

Marlot van der Wal is a scholar working on Immunology, Dermatology and Immunology and Allergy. According to data from OpenAlex, Marlot van der Wal has authored 15 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 5 papers in Dermatology and 3 papers in Immunology and Allergy. Recurrent topics in Marlot van der Wal's work include T-cell and B-cell Immunology (8 papers), Immune Cell Function and Interaction (7 papers) and Dermatology and Skin Diseases (5 papers). Marlot van der Wal is often cited by papers focused on T-cell and B-cell Immunology (8 papers), Immune Cell Function and Interaction (7 papers) and Dermatology and Skin Diseases (5 papers). Marlot van der Wal collaborates with scholars based in Netherlands, United Kingdom and Germany. Marlot van der Wal's co-authors include Femke van Wijk, Sebastiaan J. Vastert, Barbara Giovannone, Judith L. Thijs, Alessandra Petrelli, Michal Mokrý, Gerdien Mijnheer, Aridaman Pandit, Jorg van Loosdregt and Marjolein de Bruin‐Weller and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Nature Immunology.

In The Last Decade

Marlot van der Wal

15 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marlot van der Wal Netherlands 10 224 96 87 61 52 15 384
Tomoko Akeda Japan 8 139 0.6× 95 1.0× 84 1.0× 31 0.5× 19 0.4× 14 330
Ángel Vera Spain 11 183 0.8× 242 2.5× 108 1.2× 101 1.7× 23 0.4× 20 473
Kenshiro Tsuda Japan 9 110 0.5× 51 0.5× 69 0.8× 30 0.5× 15 0.3× 14 266
Kimiko Kasahara Japan 11 189 0.8× 126 1.3× 50 0.6× 22 0.4× 48 0.9× 29 394
William Loo United States 9 249 1.1× 68 0.7× 19 0.2× 79 1.3× 54 1.0× 11 382
Ioannis Kalampokis United States 5 280 1.3× 37 0.4× 19 0.2× 38 0.6× 30 0.6× 10 422
Holly A. Bolton Australia 8 604 2.7× 46 0.5× 95 1.1× 22 0.4× 56 1.1× 9 705
M Svenson Denmark 9 236 1.1× 48 0.5× 20 0.2× 44 0.7× 49 0.9× 9 398
Vincenzo Carbonelli Italy 7 169 0.8× 36 0.4× 22 0.3× 143 2.3× 20 0.4× 17 359
Thomas V. Guy Australia 8 558 2.5× 36 0.4× 96 1.1× 19 0.3× 51 1.0× 10 646

Countries citing papers authored by Marlot van der Wal

Since Specialization
Citations

This map shows the geographic impact of Marlot van der Wal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marlot van der Wal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marlot van der Wal more than expected).

Fields of papers citing papers by Marlot van der Wal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marlot van der Wal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marlot van der Wal. The network helps show where Marlot van der Wal may publish in the future.

Co-authorship network of co-authors of Marlot van der Wal

This figure shows the co-authorship network connecting the top 25 collaborators of Marlot van der Wal. A scholar is included among the top collaborators of Marlot van der Wal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marlot van der Wal. Marlot van der Wal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Paganelli, Fernanda L., Joris M. van Montfrans, Pauline M. Ellerbroek, et al.. (2025). Gut microbial dysbiosis, IgA, and Enterococcus in common variable immunodeficiency with immune dysregulation. Microbiome. 13(1). 12–12. 6 indexed citations
2.
Wal, Marlot van der, Celeste M. Boesjes, Yvonne Pannekoek, et al.. (2025). Single-cell sequencing of human Langerhans cells identifies altered gene expression profiles in patients with atopic dermatitis. ImmunoHorizons. 9(2). 2 indexed citations
3.
Thijs, Judith L., Marlot van der Wal, Chantal van Luijk, et al.. (2024). Ocular surface disease in moderate‐to‐severe atopic dermatitis patients and the effect of biological therapy. Clinical & Experimental Allergy. 54(4). 241–252. 8 indexed citations
4.
5.
Thijs, Judith L., Marlot van der Wal, Chantal van Luijk, et al.. (2023). High dupilumab levels in tear fluid of atopic dermatitis patients with moderate‐to‐severe ocular surface disease. Clinical and Translational Allergy. 13(1). e12221–e12221. 8 indexed citations
6.
Thijs, Judith L., Marlot van der Wal, Chantal van Luijk, et al.. (2023). Dupilumab‐associated ocular surface disease in atopic dermatitis patients: Clinical characteristics, ophthalmic treatment response and conjunctival goblet cell analysis. Allergy. 78(8). 2266–2276. 15 indexed citations
7.
Chao, Ying-Yin, Thomas Seeholzer, Marlot van der Wal, et al.. (2023). Human TH17 cells engage gasdermin E pores to release IL-1α on NLRP3 inflammasome activation. Nature Immunology. 24(2). 295–308. 47 indexed citations
8.
Wienke, Judith, Saskia R Veldkamp, Fjodor A. Yousef Yengej, et al.. (2022). T cell interaction with activated endothelial cells primes for tissue-residency. Frontiers in Immunology. 13. 827786–827786. 12 indexed citations
9.
Wal, Marlot van der, Eelco C. Brand, Patrick Maschmeyer, et al.. (2022). Human regulatory T cells locally differentiate and are functionally heterogeneous within the inflamed arthritic joint. Clinical & Translational Immunology. 11(10). e1420–e1420. 15 indexed citations
10.
Mijnheer, Gerdien, Michal Mokrý, Marlot van der Wal, et al.. (2021). Conserved human effector Treg cell transcriptomic and epigenetic signature in arthritic joint inflammation. Nature Communications. 12(1). 2710–2710. 57 indexed citations
11.
Bakker, Daphne S., Marlot van der Wal, Barbara Giovannone, et al.. (2021). Early and Long-Term Effects of Dupilumab Treatment on Circulating T-Cell Functions in Patients with Moderate-to-Severe Atopic Dermatitis. Journal of Investigative Dermatology. 141(8). 1943–1953.e13. 53 indexed citations
12.
Lerkvaleekul, Butsabong, Saskia R Veldkamp, Marlot van der Wal, et al.. (2021). Siglec-1 expression on monocytes is associated with the interferon signature in juvenile dermatomyositis and can predict treatment response. Lara D. Veeken. 61(5). 2144–2155. 31 indexed citations
13.
Angiolilli, Chiara, Emmerik F A Leijten, Cornelis P. J. Bekker, et al.. (2021). ZFP36 Family Members Regulate the Proinflammatory Features of Psoriatic Dermal Fibroblasts. Journal of Investigative Dermatology. 142(2). 402–413. 24 indexed citations
14.
Wal, Marlot van der, Joris M. van Montfrans, Pauline M. Ellerbroek, et al.. (2021). Chronically Activated T-cells Retain Their Inflammatory Properties in Common Variable Immunodeficiency. Journal of Clinical Immunology. 41(7). 1621–1632. 16 indexed citations
15.
Petrelli, Alessandra, Gerdien Mijnheer, David P. Hoytema van Konijnenburg, et al.. (2018). PD-1+CD8+ T cells are clonally expanding effectors in human chronic inflammation. Journal of Clinical Investigation. 128(10). 4669–4681. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026